Literature DB >> 25103892

DRB1*0402 may influence arthritis by promoting naive CD4+ T-cell differentiation in to regulatory T cells.

David Luckey1, Marshall Behrens, Michele Smart, Harvinder Luthra, Chella S David, Veena Taneja.   

Abstract

HLA-DRB1*0401 expression in humans has been associated with a predisposition to developing rheumatoid arthritis (RA) and collagen-induced arthritis (CIA), while HLA-DRB1*0402 is not associated with susceptibility. Here, we determined if mice transgenic (Tg) for human *0401 have a CD4+ T-cell repertoire that predetermines proinflammatory cytokine production. The data show that both *0401 and *0402 Tg mice can produce TH1/TH17 cytokines, although the kinetics of response may be different. However, in the context of antigen-specific responses in a CIA model, *0402 Tg mice generate a TH2 response that may explain their resistance to developing arthritis. In addition, a significant subset of naïve CD4+ T cells from *0402 Tg mice can be activated in polarizing conditions to differentiate into Treg cells that produce IFN-γ. *0401 Tg mice harbor memory CD4+ T cells that differentiate into IL-17(+) cells in various polarizing conditions. Our data suggest that *0401 Tg mice generate a strong immune response to lipopolysaccharide and may be efficient in clearing infection, and may *0401 have been evolutionarily selected for this ability. Autoimmunity, such as RA, could likely be a bystander effect of the cytokine storm that, along with the presence of low Treg-cell numbers in *0401 Tg mice, causes immune dysregulation.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Humanized mice; Immune dysregulation; Regulatory T cells; Rheumatoid arthritis; T-cell polarization

Mesh:

Substances:

Year:  2014        PMID: 25103892      PMCID: PMC4232983          DOI: 10.1002/eji.201344424

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

Review 1.  Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes.

Authors:  E Möller; J Böhme; M A Valugerdi; A Ridderstad; O Olerup
Journal:  Immunol Rev       Date:  1990-12       Impact factor: 12.988

2.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

3.  High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.

Authors:  Amiel Tokayer; Steven E Carsons; Binny Chokshi; Frances Santiago-Schwarz
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

4.  Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Authors:  R Maini; E W St Clair; F Breedveld; D Furst; J Kalden; M Weisman; J Smolen; P Emery; G Harriman; M Feldmann; P Lipsky
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

Review 5.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

Authors:  P K Gregersen; J Silver; R J Winchester
Journal:  Arthritis Rheum       Date:  1987-11

6.  Molecular diversity of HLA-DR4 haplotypes.

Authors:  P K Gregersen; M Shen; Q L Song; P Merryman; S Degar; T Seki; J Maccari; D Goldberg; H Murphy; J Schwenzer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.

Authors:  A Minty; P Chalon; J M Derocq; X Dumont; J C Guillemot; M Kaghad; C Labit; P Leplatois; P Liauzun; B Miloux
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

8.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

9.  HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis.

Authors:  Veena Taneja; Neelam Taneja; Marshall Behrens; Suchong Pan; Tad Trejo; Marie Griffiths; Harvinder Luthra; Chella S David
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

10.  HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.

Authors:  B P Wordsworth; J S Lanchbury; L I Sakkas; K I Welsh; G S Panayi; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more
  10 in total

1.  Immune response to immunodominant Mycobacterium tuberculosis antigen ESAT-6 derived peptide is HLA-haplotype dependent.

Authors:  Michele Smart; Marshall Behrens; Luckey David; Catherine Conway; Veena Taneja
Journal:  Jacobs J Allergy Immunol       Date:  2014-09-05

2.  A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.

Authors:  Muhammed Yuksel; Yipeng Wang; Ningwen Tai; Jian Peng; Junhua Guo; Kathie Beland; Pascal Lapierre; Chella David; Fernando Alvarez; Isabelle Colle; Huiping Yan; Giorgina Mieli-Vergani; Diego Vergani; Yun Ma; Li Wen
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

3.  Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Heather Gordish-Dressman; Ross Fasano; Michael Riggs; Catherine Fortier; Andrew D Campbell; Dominique Charron; Victor R Gordeuk; Naomi L C Luban; Stanislav Vukmanovic; Ryad Tamouza
Journal:  Hum Immunol       Date:  2015-10-22       Impact factor: 2.850

4.  Cytokines pre-determined by genetic factors are involved in pathogenesis of Rheumatoid arthritis.

Authors:  Veena Taneja
Journal:  Cytokine       Date:  2014-12-23       Impact factor: 3.861

5.  Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis.

Authors:  Gabriele Di Sante; Barbara Tolusso; Anna Laura Fedele; Elisa Gremese; Stefano Alivernini; Chiara Nicolò; Francesco Ria; Gianfranco Ferraccioli
Journal:  EBioMedicine       Date:  2015-11-17       Impact factor: 8.143

Review 6.  Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies.

Authors:  Katina Schinnerling; Carlos Rosas; Lilian Soto; Ranjeny Thomas; Juan Carlos Aguillón
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

Review 7.  The role of microbiome in rheumatoid arthritis treatment.

Authors:  Rahul Bodkhe; Baskar Balakrishnan; Veena Taneja
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-07-30       Impact factor: 5.346

8.  Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity.

Authors:  Katherine Cook; Wei Xue; Suha Atabani; Peter Symonds; Abdullah Al Omari; Ian Daniels; Sabaria Shah; Ruhul Hasan Choudhury; Daisy Weston; Rachael Metheringham; Victoria Brentville; Lindy Durrant
Journal:  Front Immunol       Date:  2022-04-08       Impact factor: 8.786

9.  Immunity to Influenza is dependent on MHC II polymorphism: study with 2 HLA transgenic strains.

Authors:  David Luckey; Eric A Weaver; Douglas G Osborne; Daniel D Billadeau; Veena Taneja
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

10.  The influence of HLA genotype on the severity of COVID-19 infection.

Authors:  David J Langton; Stephen C Bourke; Benedicte A Lie; Gabrielle Reiff; Shonali Natu; Rebecca Darlay; John Burn; Carlos Echevarria
Journal:  HLA       Date:  2021-05-04       Impact factor: 4.513

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.